1 February 2024 false No description of principal activity Taxfiler 2024.6 true 13834702business:PrivateLimitedCompanyLtd2024-02-012025-01-31 138347022024-01-31 13834702business:EntityHasNeverTraded2024-02-012025-01-31 138347022024-02-012025-01-31 13834702business:AuditExemptWithAccountantsReport2024-02-012025-01-31 13834702business:FilletedAccounts2024-02-012025-01-31 138347022025-01-31 13834702business:Director12024-02-012025-01-31 13834702business:Director22024-02-012025-01-31 13834702business:Director32024-02-012025-01-31 13834702business:RegisteredOffice2024-02-012025-01-31 138347022024-01-31 13834702core:WithinOneYear2025-01-31 13834702core:WithinOneYear2024-01-31 13834702core:AfterOneYear2025-01-31 13834702core:AfterOneYear2024-01-31 13834702core:ShareCapitalcore:PreviouslyStatedAmount2025-01-31 13834702core:ShareCapitalcore:PreviouslyStatedAmount2024-01-31 13834702core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-01-31 13834702core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-01-31 13834702core:PreviouslyStatedAmount2025-01-31 13834702core:PreviouslyStatedAmount2024-01-31 13834702business:SmallEntities2024-02-012025-01-31 13834702countries:EnglandWales2024-02-012025-01-31 13834702core:WithinOneYear2024-02-012025-01-31 13834702core:AfterOneYear2024-02-012025-01-31 13834702business:OrdinaryShareClass12024-02-012025-01-31 13834702business:OrdinaryShareClass12023-02-012024-01-31 138347022023-02-012024-01-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 13834702 (England and Wales)
Trueview Medical Ltd Unaudited accounts for the year ended 31 January 2025
Trueview Medical Ltd Unaudited accounts Contents
Page
- 2 -
Trueview Medical Ltd Company Information for the year ended 31 January 2025
Directors
Dr Kelechi Eseonu Christopher Icely Karina Torlei-Price
Company Number
13834702 (England and Wales)
Registered Office
Spaces Northgate House Upper Borough Walls Bath Avon BA1 1RG England
Accountants
Adams O'Rourke Accountants Ltd 436 Woolton Road Liverpool L25 6JQ
- 3 -
Trueview Medical Ltd Statement of financial position as at 31 January 2025
2025 
2024 
Notes
£ 
£ 
Current assets
Debtors
3,695 
1,000 
Cash at bank and in hand
112,319 
- 
116,014 
1,000 
Creditors: amounts falling due within one year
(152,020)
- 
Net current (liabilities)/assets
(36,006)
1,000 
Total assets less current liabilities
(36,006)
1,000 
Creditors: amounts falling due after more than one year
(16,000)
- 
Net (liabilities)/assets
(52,006)
1,000 
Capital and reserves
Called up share capital
1,000 
1,000 
Profit and loss account
(53,006)
- 
Shareholders' funds
(52,006)
1,000 
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 29 August 2025 and were signed on its behalf by
Karina Torlei-Price Director Company Registration No. 13834702
- 4 -
Trueview Medical Ltd Notes to the Accounts for the year ended 31 January 2025
1
Statutory information
Trueview Medical Ltd is a private company, limited by shares, registered in England and Wales, registration number 13834702. The registered office is Spaces, Northgate House, Upper Borough Walls, Bath, Avon, BA1 1RG, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Research and development
All research costs are expensed. Costs related to the development of products are capitalised when they meet the criteria stated in FRS 102, Section 18 Intangible assets other than Goodwill. All other development expenditure is recognised as an expense in the period in which it is incurred.
Foreign exchange
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Grant income
A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised asa a liability.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt ther going concern basis of accounting in preparing its financial statements.
4
Debtors
2025 
2024 
£ 
£ 
Amounts falling due within one year
VAT
1,717 
- 
Accrued income and prepayments
1,978 
- 
Other debtors
- 
1,000 
3,695 
1,000 
- 5 -
Trueview Medical Ltd Notes to the Accounts for the year ended 31 January 2025
5
Creditors: amounts falling due within one year
2025 
2024 
£ 
£ 
Trade creditors
3,415 
- 
Other creditors
105,000 
- 
Loans from directors
42,955 
- 
Accruals
650 
- 
152,020 
- 
A the balance sheet date, the company had oustanding convertible loans of £105,000, which are due to convert into equity within 5 months. The loans are non-interest bearing. See also related party note.
6
Creditors: amounts falling due after more than one year
2025 
2024 
£ 
£ 
Other creditors
16,000 
- 
A the balance sheet date, the company had loans to related party companies of £16,000, which are interest free and repayable on demand. See also related party note.
7
Share capital
2025 
2024 
£ 
£ 
Allotted, called up and fully paid:
1,000,000 Ordinary shares of £0.001 each
1,000 
1,000 
8
Transactions with related parties
At the balance sheet date, thecompany owed £42,955 to directors. The amounts relate to wages payable: C Icely: £16,190 K Eseonu: £9,280 K Torlei-Price: £17,485 During the year, the company received a loan of £8k from Epitechne Ltd (under control of director C Icely), and £8k from Medical UX Ltd (under control of director K Torlei-Price). Both loans are interest free and repayable on demand.
9
Average number of employees
During the year the average number of employees was 3 (2024: 0).
- 6 -